These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 35200603)

  • 61. Comprehensive genomic profiling of small bowel adenocarcinoma by tissue and plasma biopsy.
    Yu D; Wang J; Zheng B; Yuan M; Gu D; Chen R; Chen X
    Genomics; 2024 Jan; 116(1):110766. PubMed ID: 38141930
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Small bowel nonendocrine neoplasms: current concepts and novel perspectives.
    Piscaglia AC; Campanale M; Gasbarrini G
    Eur Rev Med Pharmacol Sci; 2010 Apr; 14(4):320-6. PubMed ID: 20496542
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Personalized four-category staging for predicting prognosis in patients with small bowel Adenocarcinoma: an international development and validation study.
    Dai ZH; Wang QW; Zhang QW; Yan XL; Aparicio T; Zhou YY; Wang H; Zhang CH; Zaanan A; Afchain P; Zhang Y; Chen HM; Gao YJ; Ge ZZ
    EBioMedicine; 2020 Oct; 60():102979. PubMed ID: 32980692
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Enhancing treatment strategies for small bowel cancer: a clinical review of targeted therapy and immunotherapy approaches.
    Ebrahimpour M; Hosseinzadeh H; Abedi F; Nodeh MM; Allahyari A; Sahebkar A; Arasteh O
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Jul; 397(7):4601-4614. PubMed ID: 38329524
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Small bowel adenocarcinoma: a rare but aggressive disease.
    Delaunoit T; Neczyporenko F; Limburg PJ; Erlichman C
    Clin Colorectal Cancer; 2004 Nov; 4(4):241-8; discussion 249-51. PubMed ID: 15555205
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Malignant tumours of the small bowel.
    Donohue JH
    Surg Oncol; 1994 Apr; 3(2):61-8. PubMed ID: 7952393
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Small bowel tumors: pathology and management.
    Williamson JM; Williamson RC
    J Med Assoc Thai; 2014 Jan; 97(1):126-37. PubMed ID: 24701741
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Nomograms predict survival of patients with small bowel adenocarcinoma: a SEER-based study.
    Zheng Z; Zhou X; Zhang J; Zhao B; Chen C; Liu X; Cao H; Li T; Geng R; Wang W; Li Y
    Int J Clin Oncol; 2021 Feb; 26(2):387-398. PubMed ID: 33113018
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Natural history and prognostic factors for localised small bowel adenocarcinoma.
    Colina A; Hwang H; Wang H; Katz MHG; Sun R; Lee JE; Thomas J; Tzeng CW; Wolff RA; Raghav K; Overman MJ
    ESMO Open; 2020 Nov; 5(6):e000960. PubMed ID: 33188051
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The clinical pathological features, diagnosis, treatment and prognosis of small intestine primary malignant tumors.
    Guo X; Mao Z; Su D; Jiang Z; Bai L
    Med Oncol; 2014 Apr; 31(4):913. PubMed ID: 24639284
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Beyond bevacizumab: a review of targeted agents in metastatic small bowel adenocarcinoma.
    Sacdalan DB; Mendoza MJ; Vergara JP; Catedral LI; Ting FI; Leones LM; Berba CM; Sacdalan DL
    Med Oncol; 2020 Nov; 37(11):106. PubMed ID: 33135102
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Prognostic factors and treatment outcomes in patients with Small Bowel Adenocarcinoma (SBA): the Royal Marsden Hospital (RMH) experience.
    Khan K; Peckitt C; Sclafani F; Watkins D; Rao S; Starling N; Jain V; Trivedi S; Stanway S; Cunningham D; Chau I
    BMC Cancer; 2015 Jan; 15():15. PubMed ID: 25603878
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Malignant tumors of the small intestine--new insights into a rare disease.
    Kariv R; Arber N
    Isr Med Assoc J; 2003 Mar; 5(3):188-92. PubMed ID: 12725140
    [No Abstract]   [Full Text] [Related]  

  • 74. Addition of Bevacizumab to First-Line Palliative Chemotherapy in Patients with Metastatic Small Bowel Adenocarcinoma: A Population-Based Study.
    Legué LM; van Erning FN; Bernards N; Lemmens VEPP; de Hingh IHJT; Creemers GJ
    Target Oncol; 2019 Dec; 14(6):699-705. PubMed ID: 31625001
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Bevacizumab combined with capecitabine and oxaliplatin in patients with advanced adenocarcinoma of the small bowel or ampulla of vater: A single-center, open-label, phase 2 study.
    Gulhati P; Raghav K; Shroff RT; Varadhachary GR; Kopetz S; Javle M; Qiao W; Wang H; Morris J; Wolff RA; Overman MJ
    Cancer; 2017 May; 123(6):1011-1017. PubMed ID: 27859010
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A Single Institutional Analysis of Systemic Therapy for Unresectable or Recurrent Small Bowel Adenocarcinoma.
    Makino S; Takahashi H; Haraguchi N; Nishimura J; Hata T; Matsuda C; Ikenaga M; Murata K; Yamamoto H; Doki Y; Mori M; Mizushima T
    Anticancer Res; 2017 Mar; 37(3):1495-1500. PubMed ID: 28314324
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Tumors of the small intestine].
    Gräter H
    Praxis (Bern 1994); 2002 Oct; 91(41):1699-704. PubMed ID: 12422774
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Small bowel adenocarcinoma: understaged and undertreated?
    Nicholl MB; Ahuja V; Conway WC; Vu VD; Sim MS; Singh G
    Ann Surg Oncol; 2010 Oct; 17(10):2728-32. PubMed ID: 20458546
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Prognostic Role of Body Mass Index in Advanced Small Bowel Adenocarcinoma Patients Receiving Palliative Chemotherapy.
    Lee DW; Lee KH; Kim TY; Han SW; Oh DY; Im SA; Kim TY; Bang YJ
    Nutr Cancer; 2016 Jul; 68(5):750-5. PubMed ID: 27282771
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Progression of diagnosis and treatment in primary malignant small bowel tumor].
    Zhao Z; Guan X; Chen Y; Wang X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Jan; 20(1):117-120. PubMed ID: 28105627
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.